Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
The Oncologist
|
March 11, 2022
Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology Practices
Andrew J Klink, Landon Z Marshall, Abdalla Aly, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 17, 2013
Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival
Ian M Breunig, Fadia T Shaya, Nader Hanna, et al.
American Journal of Clinical Oncology
|
September 26, 2013
Multispecialist Care and Mortality in Hepatocellular Carcinoma
Viktor V Chirikov, C Daniel Mullins, Nader Hanna, et al.
BMC Cancer
|
April 7, 2020
Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis
Ryan N Hansen, Yiduo Zhang, Brian Seal, et al.
Journal of Occupational and Environmental Medicine
|
January 1, 2010
The cost of poor sleep: workplace productivity loss and associated costs
Mark R Rosekind, Kevin B Gregory, Melissa M Mallis, et al.
General Dentistry
|
November 11, 2010
Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S
Grant H Skrepnek, Brian Seal, Muralikrishna Tangirala, et al.
Journal of the American Geriatrics Society
|
April 2, 2011
Chemotherapy treatment and survival in older women with estrogen receptor-negative metastatic breast cancer: a population-based analysis
Myra Schneider, Ilene H Zuckerman, Eberechukwu Onukwugha, et al.
Pharmacoeconomics
|
December 3, 2013
Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare
Fadia T Shaya, Ian M Breunig, Brian Seal, et al.
The Journal of Allergy and Clinical Immunology
|
March 4, 2008
Asthma costs and utilization in a managed care organization
Robert S Zeiger, Joel W Hay, Richard Contreras, et al.
Leukemia & Lymphoma
|
October 3, 2018
Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United States
Ravi K Goyal, Saurabh P Nagar, Shaum M Kabadi, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
The Oncologist
|
March 11, 2022
Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology Practices
Andrew J Klink, Landon Z Marshall, Abdalla Aly, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 17, 2013
Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival
Ian M Breunig, Fadia T Shaya, Nader Hanna, et al.
American Journal of Clinical Oncology
|
September 26, 2013
Multispecialist Care and Mortality in Hepatocellular Carcinoma
Viktor V Chirikov, C Daniel Mullins, Nader Hanna, et al.
BMC Cancer
|
April 7, 2020
Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis
Ryan N Hansen, Yiduo Zhang, Brian Seal, et al.
Journal of Occupational and Environmental Medicine
|
January 1, 2010
The cost of poor sleep: workplace productivity loss and associated costs
Mark R Rosekind, Kevin B Gregory, Melissa M Mallis, et al.
General Dentistry
|
November 11, 2010
Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S
Grant H Skrepnek, Brian Seal, Muralikrishna Tangirala, et al.
Journal of the American Geriatrics Society
|
April 2, 2011
Chemotherapy treatment and survival in older women with estrogen receptor-negative metastatic breast cancer: a population-based analysis
Myra Schneider, Ilene H Zuckerman, Eberechukwu Onukwugha, et al.
Pharmacoeconomics
|
December 3, 2013
Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare
Fadia T Shaya, Ian M Breunig, Brian Seal, et al.
The Journal of Allergy and Clinical Immunology
|
March 4, 2008
Asthma costs and utilization in a managed care organization
Robert S Zeiger, Joel W Hay, Richard Contreras, et al.
Leukemia & Lymphoma
|
October 3, 2018
Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United States
Ravi K Goyal, Saurabh P Nagar, Shaum M Kabadi, et al.
Page
of 6